Skip to main content

Table 3 Clinical Outcome during in-hospital and 30-day follow-up in diabetic and non-diabetic patients

From: Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions

   DM Non-DM P
Subject number (n) 237 73 164 NA
Composite MACE 35 (14.8) 18 (24.7) 17 (10.4) 0.004
Cardiac death 4 (1.7) 2 (2.7) 2 (1.2) 0.770
Reinfarction 3 (1.3) 2 (2.7) 1 (0.6) 0.469
Repeated TVR 3 (1.3) 1 (1.4) 2 (1.2) 0.594
Recurrent angina 15 (6.3) 9 (12.3) 6 (3.7) 0.025
Malignant arrhythmia 10 (4.2) 5 (6.8) 5 (3) 0.320
Non-cardiac death 1 (0.4) 0 (0) 1 (0.6) 0.678
Non-IRA revascularization 53 (22.4) 27 (37) 26 (16) 0.001
  1. Data given as mean ± SD or n (%).
  2. MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.
Back to article page